Selective Modulation of Protein Kinase C α over Protein Kinase C ϵ by Curcumin and Its Derivatives in CHO-K1 Cells

Biochemistry

Volumn 55, Issue 14, 2016, Pages 2135-2143

  Pany, Satyabrata ^a   Majhi, Anjoy ^a   Das, Joydip ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL DEATH; CHAINS; MEMBRANES; MODULATION; PROTEINS;

ACTIVE CONSTITUENTS; CELLULAR FUNCTION; INHIBITION PROPERTY; LITERATURE DATA; LONG ALIPHATIC CHAIN; MEMBRANE TRANSLOCATION; PROTEIN KINASE C; UNSATURATED DOUBLE BONDS;

ENZYMES;

1 [4 (HEXADECYLOXY) 3 METHOXYPHENYL] 7 (4 HYDROXY 3 METHOXYPHENYL)HEPTA 1,6 DIENE 3,5 DIONE; 4 [3 HYDROXY 4 [3 HYDROXY 7 (4 HYDROXY 3 METHOXYPHENYL) 5 OXOHEPTA 2,6 DIEN 1 YL] 2 METHOXYPHENYL OCTADECA 9,12,15 TRIENOATE; 4 [3 HYDROXY 7 (4 HYDROXY 3 METHOXYPHENYL) 5 OXOHEPTA 2,6 DIEN 1 YL] 2 METHOXYPHENYL OCTADECA 9,12 DIENOATE; 4 [3 HYDROXY 7 (4 HYDROXY 3 METHOXYPHENYL) 5 OXOHEPTA 2,6 DIEN 1 YL] 2 METHOXYPHENYL OLEATE; ANTIOXIDANT; CURCUMIN; DIDEMETHYLCURCUMIN; HYDROXYL GROUP; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C ALPHA; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOBLOTTING; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CHEMISTRY; CHO CELL LINE; COMPARATIVE STUDY; CRICETULUS; DRUG DESIGN; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; KINETICS; LIPOYLATION; METABOLISM; METHYLATION; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL MEMBRANE; CELL SURVIVAL; CHO CELLS; CRICETULUS; CURCUMIN; DRUG DESIGN; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KINETICS; LIPOYLATION; MAP KINASE SIGNALING SYSTEM; METHYLATION; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 84964679032     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.6b00057     Document Type: Article

References (65)

1. Battaini, F. and Mochly-Rosen, D. (2007) Happy birthday protein kinase C: past, present and future of a superfamily Pharmacol. Res. 55, 461-466 10.1016/j.phrs.2007.05.005
2. Koivunen, J., Aaltonen, V., and Peltonen, J. (2006) Protein kinase C (PKC) family in cancer progression Cancer Lett. 235, 1-10 10.1016/j.canlet.2005.03.033
3. Griner, E. M. and Kazanietz, M. G. (2007) Protein kinase C and other diacylglycerol effectors in cancer Nat. Rev. Cancer 7, 281-294 10.1038/nrc2110
4. Das Evcimen, N. and King, G. L. (2007) The role of protein kinase C activation and the vascular complications of diabetes Pharmacol. Res. 55, 498-510 10.1016/j.phrs.2007.04.016
5. Bright, R. and Mochly-Rosen, D. (2005) The role of protein kinase C in cerebral ischemic and reperfusion injury Stroke 36, 2781-2790 10.1161/01.STR.0000189996.71237.f7
6. Chou, W. H. and Messing, R. O. (2005) Protein kinase C isozymes in stroke Trends Cardiovasc. Med. 15, 47-51 10.1016/j.tcm.2005.01.003
7. Sabri, A. and Steinberg, S. F. (2003) Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure Mol. Cell. Biochem. 251, 97-101 10.1023/A:1025490017780
8. Alkon, D. L., Sun, M. K., and Nelson, T. J. (2007) PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease Trends Pharmacol. Sci. 28, 51-60 10.1016/j.tips.2006.12.002
9. Hofmann, J. (2004) Protein kinase C isozymes as potential targets for anticancer therapy Curr. Cancer Drug Targets 4, 125-146 10.2174/1568009043481579
10. Mochly-Rosen, D., Das, K., and Grimes, K. V. (2012) Protein kinase C, an elusive therapeutic target? Nat. Rev. Drug Discovery 11, 937-957 10.1038/nrd3871
11. Newton, A. C. (2001) Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions Chem. Rev. 101, 2353-2364 10.1021/cr0002801
12. Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C Science 258, 607-614 10.1126/science.1411571
13. Colon-Gonzalez, F. and Kazanietz, M. G. (2006) C1 domains exposed: from diacylglycerol binding to protein-protein interactions Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1761, 827-837 10.1016/j.bbalip.2006.05.001
14. Yang, C. and Kazanietz, M. G. (2003) Divergence and complexities in DAG signaling: looking beyond PKC Trends Pharmacol. Sci. 24, 602-608 10.1016/j.tips.2003.09.003
15. Sharkey, N. A. and Blumberg, P. M. (1986) Comparison of the activity of phorbol 12-myristate 13-acetate and the diglyceride glycerol 1-myristate 2-acetate Carcinogenesis 7, 677-679 10.1093/carcin/7.4.677
16. Kazanietz, M. G., Krausz, K. W., and Blumberg, P. M. (1992) Differential irreversible insertion of protein kinase C into phospholipid vesicles by phorbol esters and related activators J. Biol. Chem. 267, 20878-20886
17. Boije af Gennas, G., Talman, V., Yli-Kauhaluoma, J., Tuominen, R. K., and Ekokoski, E. (2011) Current status and future prospects of c1 domain ligands as drug candidates Curr. Top. Med. Chem. 11, 1370-1392 10.2174/156802611795589584
18. Blumberg, P. M., Kedei, N., Lewin, N. E., Yang, D., Czifra, G., Pu, Y., Peach, M. L., and Marquez, V. E. (2008) Wealth of opportunity-the C1 domain as a target for drug development Curr. Drug Targets 9, 641-652 10.2174/138945008785132376
19. Goel, A. and Aggarwal, B. B. (2010) Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs Nutr. Cancer 62, 919-930 10.1080/01635581.2010.509835
20. Epstein, J., Sanderson, I. R., and Macdonald, T. T. (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies Br. J. Nutr. 103, 1545-1557 10.1017/S0007114509993667
21. Singh, S. (2007) From exotic spice to modern drug? Cell 130, 765-768 10.1016/j.cell.2007.08.024
22. Ataie, A., Sabetkasaei, M., Haghparast, A., Moghaddam, A. H., Ataee, R., and Moghaddam, S. N. (2010) Curcumin exerts neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain J. Med. Food 13, 821-826 10.1089/jmf.2009.1278
23. Cemil, B., Topuz, K., Demircan, M. N., Kurt, G., Tun, K., Kutlay, M., Ipcioglu, O., and Kucukodaci, Z. (2010) Curcumin improves early functional results after experimental spinal cord injury Acta Neurochir. 152, 1583-1590 (discussion) 10.1007/s00701-010-0702-x
24. Morimoto, T., Sunagawa, Y., Fujita, M., and Hasegawa, K. (2010) Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin Circ. J. 74, 1059-1066 10.1253/circj.CJ-09-1012
25. Lin, J. K., Chen, Y. C., Huang, Y. T., and Lin-Shiau, S. Y. (1997) Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin J. Cell. Biochem. 67, 39-48 10.1002/(SICI)1097-4644(1997)28/29+<39::AID-JCB5>3.0.CO;2-X
26. Rungseesantivanon, S., Thenchaisri, N., Ruangvejvorachai, P., and Patumraj, S. (2010) Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition BMC Complementary Altern. Med. 10, 57 10.1186/1472-6882-10-57
27. Lin, J. K. (2007) Molecular targets of curcumin Adv. Exp. Med. Biol. 595, 227-243 10.1007/978-0-387-46401-5_10
28. Balasubramanyam, M., Koteswari, A. A., Kumar, R. S., Monickaraj, S. F., Maheswari, J. U., and Mohan, V. (2003) Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications J. Biosci. 28, 715-721 10.1007/BF02708432
29. Liu, J. Y., Lin, S. J., and Lin, J. K. (1993) Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells Carcinogenesis 14, 857-861 10.1093/carcin/14.5.857
30. Reddy, S. and Aggarwal, B. B. (1994) Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase FEBS Lett. 341, 19-22 10.1016/0014-5793(94)80232-7
31. Mahmmoud, Y. A. (2007) Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions Br. J. Pharmacol. 150, 200-208 10.1038/sj.bjp.0706970
32. Perez-Lara, A., Corbalan-Garcia, S., and Gomez-Fernandez, J. C. (2011) Curcumin modulates PKCalpha activity by a membrane-dependent effect Arch. Biochem. Biophys. 513, 36-41 10.1016/j.abb.2011.06.010
33. Garg, R., Ramchandani, A. G., and Maru, G. B. (2008) Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin Carcinogenesis 29, 1249-1257 10.1093/carcin/bgn114
34. Majhi, A., Rahman, G. M., Panchal, S., and Das, J. (2010) Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C Bioorg. Med. Chem. 18, 1591-1598 10.1016/j.bmc.2009.12.075
35. Das, J., Pany, S., Panchal, S., Majhi, A., and Rahman, G. M. (2011) Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C Bioorg. Med. Chem. 19, 6196-6202 10.1016/j.bmc.2011.09.011
36. Pany, S., Majhi, A., and Das, J. (2012) PKC activation by resveratrol derivatives with unsaturated aliphatic chain PLoS One 7, e52888 10.1371/journal.pone.0052888
37. Nguyen, T. V., Poole, D. P., Harvey, J. R., Stebbing, M. J., and Furness, J. B. (2005) Investigation of PKC isoform-specific translocation and targeting of the current of the late afterhyperpolarizing potential of myenteric AH neurons Eur. J. Neurosci. 21, 905-913 10.1111/j.1460-9568.2005.03931.x
38. Leterrier, C., Bonnard, D., Carrel, D., Rossier, J., and Lenkei, Z. (2004) Constitutive endocytic cycle of the CB1 cannabinoid receptor J. Biol. Chem. 279, 36013-36021 10.1074/jbc.M403990200
39. Ferrari, E., Pignedoli, F., Imbriano, C., Marverti, G., Basile, V., Venturi, E., and Saladini, M. (2011) Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity J. Med. Chem. 54, 8066-8077 10.1021/jm200872q
40. Wilken, R., Veena, M. S., Wang, M. B., and Srivatsan, E. S. (2011) Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma Mol. Cancer 10, 12 10.1186/1476-4598-10-12
41. Hossain, D. S., Bhattacharyya, S., Das, T., and Sa, G. (2012) Curcumin: The multi-targeted therapy for cancer regression Front. Biosci., Scholar Ed. S4, 335-355 10.2741/272
42. Jiang, M. C., Yang-Yen, H. F., Yen, J. J., and Lin, J. K. (1996) Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines Nutr. Cancer 26, 111-120 10.1080/01635589609514468
43. Das, J. and Rahman, G. M. (2014) C1 domains: structure and ligand-binding properties Chem. Rev. 114, 12108-12131 10.1021/cr300481j
44. Endo, Y., Yamaguchi, M., Hirano, M., and Shudo, K. (1996) Role of hydrophobic moiety of tumor promoters. Synthesis and activity of 9-alkylated banzolactams Chem. Pharm. Bull. 44, 1138-1140 10.1248/cpb.44.1138
45. Endo, Y. and Yokoyama, A. (2000) Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams Bioorg. Med. Chem. Lett. 10, 63-66 10.1016/S0960-894X(99)00580-6
46. Das, J., Pany, S., and Majhi, A. (2011) Chemical modifications of resveratrol for improved protein kinase C alpha activity Bioorg. Med. Chem. 19, 5321-5333 10.1016/j.bmc.2011.08.008
47. Shirai, Y., Kashiwagi, K., Yagi, K., Sakai, N., and Saito, N. (1998) Distinct effects of fatty acids on translocation of gamma- and epsilon-subspecies of protein kinase C J. Cell Biol. 143, 511-521 10.1083/jcb.143.2.511
48. Zhang, Q., Zhong, Y., Yan, L. N., Sun, X., Gong, T., and Zhang, Z. R. (2011) Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents Bioorg. Med. Chem. Lett. 21, 1010-1014 10.1016/j.bmcl.2010.12.020
49. Adams, B. K., Ferstl, E. M., Davis, M. C., Herold, M., Kurtkaya, S., Camalier, R. F., Hollingshead, M. G., Kaur, G., Sausville, E. A., Rickles, F. R., Snyder, J. P., Liotta, D. C., and Shoji, M. (2004) Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents Bioorg. Med. Chem. 12, 3871-3883 10.1016/j.bmc.2004.05.006
50. Hansch, C., Bonavida, B., Jazirehi, A. R., Cohen, J. J., Milliron, C., and Kurup, A. (2003) Quantitative structure-Activity relationships of phenolic compounds causing apoptosis Bioorg. Med. Chem. 11, 617-620 10.1016/S0968-0896(02)00326-7
51. Fujisawa, S., Atsumi, T., Ishihara, M., and Kadoma, Y. (2004) Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds Anticancer Res. 24, 563-569
52. Priyadarsini, K. I., Maity, D. K., Naik, G. H., Kumar, M. S., Unnikrishnan, M. K., Satav, J. G., and Mohan, H. (2003) Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin Free Radical Biol. Med. 35, 475-484 10.1016/S0891-5849(03)00325-3
53. Stubbs, C. D. and Slater, S. J. (1996) The effects of non-lamellar forming lipids on membrane protein-lipid interactions Chem. Phys. Lipids 81, 185-195 10.1016/0009-3084(96)02581-9
54. Goldberg, E. M. and Zidovetzki, R. (1997) Effects of dipalmitoylglycerol and fatty acids on membrane structure and protein kinase C activity Biophys. J. 73, 2603-2614 10.1016/S0006-3495(97)78290-0
55. Giorgione, J. R., Kraayenhof, R., and Epand, R. M. (1998) Interfacial membrane properties modulate protein kinase C activation: role of the position of acyl chain unsaturation Biochemistry 37, 10956-10960 10.1021/bi980185a
56. O'Flaherty, J. T., Chadwell, B. A., Kearns, M. W., Sergeant, S., and Daniel, L. W. (2001) Protein kinases C translocation responses to low concentrations of arachidonic acid J. Biol. Chem. 276, 24743-24750 10.1074/jbc.M101093200
57. Slater, S. J., Kelly, M. B., Yeager, M. D., Larkin, J., Ho, C., and Stubbs, C. D. (1996) Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins Lipids 31, S189-192 10.1007/BF02637074
58. Medkova, M. and Cho, W. (1998) Differential membrane-binding and activation mechanisms of protein kinase C-alpha and -epsilon Biochemistry 37, 4892-4900 10.1021/bi972495j
59. Stahelin, R. V., Digman, M. A., Medkova, M., Ananthanarayanan, B., Melowic, H. R., Rafter, J. D., and Cho, W. (2005) Diacylglycerol-induced membrane targeting and activation of protein kinase Cepsilon: mechanistic differences between protein kinases Cdelta and Cepsilon J. Biol. Chem. 280, 19784-19793 10.1074/jbc.M411285200
60. Hung, W. C., Chen, F. Y., Lee, C. C., Sun, Y., Lee, M. T., and Huang, H. W. (2008) Membrane-thinning effect of curcumin Biophys. J. 94, 4331-4338 10.1529/biophysj.107.126888
61. Barry, J., Fritz, M., Brender, J. R., Smith, P. E., Lee, D. K., and Ramamoorthy, A. (2009) Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin J. Am. Chem. Soc. 131, 4490-4498 10.1021/ja809217u
62. Perez-Lara, A., Ausili, A., Aranda, F. J., de Godos, A., Torrecillas, A., Corbalan-Garcia, S., and Gomez-Fernandez, J. C. (2010) Curcumin disorders 1,2-dipalmitoyl-sn-glycero-3-phosphocholine membranes and favors the formation of nonlamellar structures by 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine J. Phys. Chem. B 114, 9778-9786 10.1021/jp101045p
63. Nakashima, S. (2002) Protein kinase C alpha (PKC alpha): regulation and biological function J. Biochem. 132, 669-675 10.1093/oxfordjournals.jbchem.a003272
64. Liu, Q. and Molkentin, J. D. (2011) Protein kinase Calpha as a heart failure therapeutic target J. Mol. Cell. Cardiol. 51, 474-478 10.1016/j.yjmcc.2010.10.004
65. Teicher, B. A. (2006) Protein kinase C as a therapeutic target Clin. Cancer Res. 12, 5336-5345 10.1158/1078-0432.CCR-06-0945